All In MedTech

Device Trial Radar · NCT04811235

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial

"OMNI-SCI" Trial - "Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury" Trial

Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

1

Actual

Start

Sep 24, 2022

Primary completion

Oct 26, 2022

Study completion Apr 1, 2026

Sponsor

Lead sponsor
University of British ColumbiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
United States Department of Defense; Congressionally Directed Medical Research Programs
First posted
Mar 23, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
No
Who can join
All sexes, from 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time. Our testing of this novel NIRS sensor in patients with acute SCI represents the first step in translating this technology for human use.

Conditions

  • Acute Spinal Cord Injury
  • Spinal Cord Injuries

Interventions

  • Near Infra-Red Spectroscopy (NIRS) SensorDevice

    The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Feasibility Assessment - OverallTime frame: Day 7
  2. Feasibility Assessment: Sensor ApplicationTime frame: Day 1
  3. Feasibility Assessment: Sensor RemovalTime frame: Day 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.